Skip to main content
Premium Trial:

Request an Annual Quote

Maybe They Need to Make It More Glamorous

Clinical trials in the US are suffering from a lack of patients, says the Los Angeles Times. Americans are not enrolling in clinical trials -- fewer than 5 percent of cancer patients enter clinical trials -- and this is partly due to patients not understanding that they will receive the standard of care, not a placebo, or receive standard care plus the experimental treatment. Some researchers are trying to boost enrollment by backing legislation to require insurance companies to pay for care during a clinical trial and by involving the patient in the process by including a patient advocate on the steering committee and briefing the patients on the study's outcome.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.